Posts Tagged ‘compounding’
FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products
FDA has received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products.
[...]Patients face safety risks with counterfeit and compounded prescription weight-loss drugs
Officials are concerned about compounded weight-loss medicines as demand surges. Share this PDF to spread the news
[...]Patients face safety risks with counterfeit and compounded prescription weight-loss drugs
Patients face safety risks with counterfeit and compounded prescription weight-loss drugs Officials warn of counterfeit and compounding pharmacy concerns as demand for weight-loss medicines surges. Demand is skyrocketing for FDA-approved medicines that provide incredible benefits to patients living with diabetes and obesity. The injectables – GLP-1s like semaglutide and incretins that are commonly known as…
[...]Have patients been harmed by unsafe drug compounding?
Have patients been harmed by unsafe drug compounding? Compounded medicine is an important part of our healthcare system. It’s meant to be an exception to the normal drug supply chain, helping patients who cannot take a drug in its existing form or filling in when there are shortages of a life-saving medication. However, compounding pharmacies…
[...]Problems inspectors found in compounding facilities
Problems inspectors found in compounding facilities There are two types of compounding pharmacies that help patients. 503A pharmacies provide bespoke medications to suit patients’ requirements if mass-produced medicine can’t meet them. 503B pharmacies, known as outsourcing facilities, can create large batches of medication specifically for healthcare facilities to use in-office. There are approximately 7,500 compounding…
[...]Lawsuits filed against businesses selling compounded injectables for diabetes and weight-loss
Lawsuits filed against businesses selling compounded injectables for diabetes and weight-loss Novo Nordisk and Eli Lilly, who developed and won FDA approval for their blockbuster weight-loss and diabetes medicines, Ozempic, Wegovy, Mounjaro and Zepbound, have been suing businesses who they say are marketing compounded versions of these drugs with false claims. These medical spas, wellness…
[...]Novo Nordisk v Champion Health And Wellness Clinics LLC, Complaint
Return to the list of compounded GLP-1 lawsuits United States District Court Southern District of Texas Novo Nordisk v Champion Health and Wellness Clinics LLC Complaint June 20, 2023 Read the document.
[...]Novo Nordis v Effinger Health, P.A. dba Nuvida Rx Weight Loss – Tallahassee Clinic , Complaint
Return to the list of compounded GLP-1 lawsuits United States District Court Northern District of Florida Novo Nordisk v Effinger Health, P.A. dba Nuvida Rx Weight Loss – Tallahassee Clinic Complaint June 20, 2023 Read the document.
[...]Novo Nordisk v. Ekzotika Corp dba Cosmetic Laser Professionals Med Spa, Complaint
Return to the list of compounded GLP-1 lawsuits United States District Court Southern District of Florida Novo Nordisk v. Ekzotika Corp dba Cosmetic Laser Professionals Med Spa Complaint June 20, 2023 Read the document.
[...]Novo Nordisk v Pro Health Investments, Complaint
Return to the list of compounded GLP-1 lawsuits United States District Court Western District of Tennessee Novo Nordisk v Pro Health Investments, LLC Complaint June 20, 2023 Read the document.
[...]